Tag: gilead-sciences
-
Gilead wins U.S. nod for drug for all types of hepatitis C
(Reuters) – U.S. health regulators on Tuesday approved a combination drug by Gilead Sciences Inc that is the first available treatment for all six major forms of hepatitis C, advancing the company’s leadership in the field and sending its shares up almost 4 percent. Gilead has dominated the hepatitis C market over rivals AbbVie and…
-
Southeast Asian fires emitted most carbon since 1997: scientists
By Beh Lih Yi JAKARTA (Thomson Reuters Foundation) – Forest fires that blanketed Southeast Asia in thick haze last year released the greatest amount of climate-changing carbon since record blazes in 1997, producing emissions higher than in the whole of the European Union, scientists said on Tuesday. Singapore, Malaysia and northern Indonesia choked under a…
-
Merck patents on Hepatitis C treatment found valid in Gilead dispute
By Rory Carroll and Andrew Chung SAN JOSE (Reuters) – Merck & Co told a federal jury on Tuesday it was seeking more than $2 billion in damages from rival Gilead Sciences Inc after the jury upheld the validity of two Merck patents in a high-profile dispute over Gilead's blockbuster cure for hepatitis C. After…
-
Syrian refugees denied critical healthcare in Jordan: Amnesty
Syrian refugees in Jordan are finding it very difficult to get medical care because of Jordanian fees and bureaucracy, and shrinking humanitarian financial support, rights group Amnesty International said on Wednesday. Many refugees cannot afford the fees for medical care imposed by the Jordanian government in 2014, and some, injured in the Syrian conflict, have…